Relevance of anti–platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemic — Nicolas Gendron (2025) | RDL Network
Relevance of anti–platelet factor 4/heparin antibodies and platelet activation in systemic inflammatory diseases and thrombosis disorders: insight from the COVID-19 pandemic
Xixi Jing, Min Xu, Deye Song, Tingting Yue, Yali Wang, Pan Zhang, Yanjun Zhong, Min Zhang, Tommy Tsan‐Yuk Lam, Nuno R. Faria, De Clercq Erik, Guangdi Li
David M. Smadja, David M. Smadja, Qun‐Ying Yue, Qun‐Ying Yue, Richard Chocron, Richard Chocron, Olivier Sanchez, Olivier Sanchez, Agnés Lillo‐Le Louët, Agnés Lillo‐Le Louët
Discussion(0)
No comments yet. Be the first to comment.